n-methyl-3,4-methylenedioxyamphetamine has been researched along with Aura in 2 studies
N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huntjens, DW | 1 |
| Weersink, EPS | 1 |
| Hilarius, DL | 1 |
| Ran, NC | 1 |
| Franssen, EJF | 1 |
| Vecellio, M | 1 |
| Schopper, C | 1 |
| Modestin, J | 1 |
2 other studies available for n-methyl-3,4-methylenedioxyamphetamine and Aura
| Article | Year |
|---|---|
Severe epileptic seizures after accidental MDMA exposure in a 14-month-old child.
Topics: Child; Electroencephalography; Epilepsy; Humans; Infant; N-Methyl-3,4-methylenedioxyamphetamine; Sei | 2022 |
Neuropsychiatric consequences (atypical psychosis and complex-partial seizures) of ecstasy use: possible evidence for toxicity-vulnerability predictors and implications for preventative and clinical care.
Topics: Adult; Amphetamine-Related Disorders; Behavior, Addictive; Epilepsy; Female; Hallucinogens; Humans; | 2003 |